Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BIOA will decline by -0.75% over the next 2 Weeks and hit $16.08 by Tuesday, June 9, 2026. In that time frame, BIOA's share price is expected to range between $14.88 and $17.13.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 9, 2026 | 14.88 | 16.08 | 17.13 |
| Jun 8, 2026 | 14.64 | 15.83 | 16.98 |
| Jun 5, 2026 | 14.84 | 16.05 | 17.16 |
| Jun 4, 2026 | 14.88 | 16.07 | 17.20 |
| Jun 3, 2026 | 15.31 | 16.44 | 17.62 |
| Jun 2, 2026 | 14.88 | 16.14 | 17.17 |
| Jun 1, 2026 | 14.79 | 15.89 | 17.07 |
| May 29, 2026 | 15.02 | 16.11 | 17.32 |
| May 28, 2026 | 14.97 | 16.13 | 17.26 |
| May 27, 2026 | 15.38 | 16.51 | 17.71 |
BIOA shares rose +4.63% in Wednesday, May 27, 2026's trading session, rising from a previous close of $16.20 to move at $16.95. The stock demonstrated notable intraday movement (see BIOA's key stats for a full breakdown), fluctuating between $16.15 and $17.18, a +6.35% trading range. While recent weeks have seen some volatility, BIOA has managed to secure a -6.82% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 586.31K shares changing hands, 375.22K more than the previous session. This amounted to $9.94M in total market activity.
Will BIOA Continue Its Upward Trend?
According to analyst ratings and projections for BIOA, BioAge Labs, Inc. shares are anticipated to increase by +1.06%, potentially reaching $17.13 per share by June 9, 2026. Short-term technical indicators currently suggest a neutral sentiment for BIOA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the BIOA stock forecast, now is a good time to buy BIOA stock because its current trading price is +5.42% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BIOA covering social and institutional perspectives.
BIOA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BIOA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 47.90% to 48.89%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.23%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.12%, maintains a neutral outlook for the long term. Insights into BIOA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BioAge Labs Short-Term Forecasts
BIOA Forecast For Next 5 Days
Our algorithm anticipates BioAge Labs (BIOA) stock could hit $14.91 by Jun 03, 2026. This represents a -12.06% rise from today's price, following a +19.44% change over the past five days.
BIOA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for BioAge Labs, Inc. (BIOA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $14.94, which would mean a -11.86% decrease from the current price of $16.95. Projections for this period range from a high of $18.39 to a low of $11.45.
BIOA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for BioAge Labs's price over the next three months point to a drop. BIOA stock is expected to peak at $21.05 on Jun 12, 2026 before potentially dipping to $9.23 on Aug 06, 2026. On average, BIOA is likely to trade around $15.74 in the coming 90 days.
BioAge Labs Stock Forecast 2025
Based on our predictive models, BioAge Labs (BIOA) is expected to trade between $9.23 and $29.08 throughout 2026. This would result in an average price of $16.26, potentially offering investors a -4.07% return from current levels.
BioAge Labs, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, BioAge Labs, Inc. (BIOA) is positioned to show a strong performance in May 2026. The price is predicted to move between $13.23 and $18.95, settling at an average of $16.01. This could translate to a -5.55% loss.
June 2026
Based on current market signals, BioAge Labs, Inc. is projected to trend june 2026. We forecast a trading range from $12.29 to $21.05, with a likely average price of $17.13. Investors could expect a potential return of +1.06%.
July 2026
Our predictive algorithms indicate BioAge Labs, Inc. stock may see a shift in July 2026. The expected range spans $11.66–$20.31, with an average target of $16.57. This represents a cautious outlook and a possible loss of -2.24%.
August 2026
Analyzing established trends, BioAge Labs, Inc. looks set to move in August 2026. Projections place the stock between $9.23 and $16.82, averaging around $13.10. This suggests a -22.71% loss from current levels.
September 2026
Market indicators suggest BioAge Labs, Inc. could experience notable changes during September 2026. Prices could fluctuate within $9.97 to $16.75, with a midpoint forecast of $13.36. The stock might deliver a -21.18% loss.
October 2026
Forecasting for October 2026, models estimate that BioAge Labs, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $11.41 and $23.44, averaging $16.27. This signals a cautious trajectory with potential returns around -4.01%.
November 2026
According to our latest forecast models, BioAge Labs, Inc. (BIOA) is positioned to show a strong performance in November 2026. The price is predicted to move between $14.63 and $29.08, settling at an average of $19.42. This could translate to a +14.57% gain.
December 2026
Based on current market signals, BioAge Labs, Inc. is projected to trend december 2026. We forecast a trading range from $11.95 to $22.00, with a likely average price of $17.92. Investors could expect a potential return of +5.72%.
January 2027
Our predictive algorithms indicate BioAge Labs, Inc. stock may see a shift in January 2027. The expected range spans $11.61–$18.38, with an average target of $14.93. This represents a cautious outlook and a possible loss of -11.92%.
February 2027
Analyzing established trends, BioAge Labs, Inc. looks set to move in February 2027. Projections place the stock between $11.98 and $18.41, averaging around $15.09. This suggests a -10.97% loss from current levels.
March 2027
Market indicators suggest BioAge Labs, Inc. could experience notable changes during March 2027. Prices could fluctuate within $12.49 to $22.19, with a midpoint forecast of $17.78. The stock might deliver a +4.90% gain.
April 2027
Forecasting for April 2027, models estimate that BioAge Labs, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $16.78 and $24.56, averaging $20.87. This signals a positive trajectory with potential returns around +23.13%.
May 2027
According to our latest forecast models, BioAge Labs, Inc. (BIOA) is positioned to show a strong performance in May 2027. The price is predicted to move between $16.37 and $23.43, settling at an average of $20.10. This could translate to a +18.58% gain.
BIOA's history of dividends and stock splits also plays a role in long-term investor confidence.

